Observational studyVirology journal2024

Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.

Marta Colaneri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.